Pathology News and Research

RSS

Pathology is the study and diagnosis of disease through examination of organs, tissues, bodily fluids, and whole bodies (autopsies). The term also encompasses the related scientific study of disease processes, called General pathology. Medical pathology is divided in two main branches, Anatomical pathology and Clinical pathology. Veterinary pathology is concerned with animal disease whereas Phytopathology is the study of plant diseases.

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

Analysis of a small number of marker genes may determine in a matter of hours if a patient with gastrointestinal stromal tumors (GIST) would respond to a targeted molecular drug regimen. This analysis could allow clinicians to determine if they have chosen the best course of action or need to consider another alternative.

15 Oct 2009

AMP congratulates SACGHS on the publication of their DNA patenting report

The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on October 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.

15 Oct 2009

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

The University of North Carolina at Chapel Hill has been awarded a five-year, $6.2 million renewal grant to continue its work as part of the National Institutes of Health's Rare Diseases Clinical Research Network (RDCRN).

14 Oct 2009

Institute of Medicine elects researcher from The Children's Hospital of Philadelphia as its member

A prominent scientist at The Children's Hospital of Philadelphia, Thomas Curran, Ph.D., FRS, has been elected to the Institute of Medicine. Dr. Curran has long been a leading researcher in pediatric oncology.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.

14 Oct 2009

Kinetic Concepts to showcase its ABThera OA NPT System at the American College of Surgeons Congress

Kinetic Concepts, Inc. will feature ABThera™ Open Abdomen Negative Pressure Therapy System, the latest addition to the KCI Negative Pressure Technology Platform (NPTP), at the American College of Surgeons’ 95th Annual Clinical Congress, Oct. 11-15 in Chicago.

13 Oct 2009

New study launched to detect DNA alterations linked to sudden cardiac death in sports

The BBVA Foundation and the Cardiology Service of Madrid's Hospital Clínico San Carlos have launched a new study aimed at detecting DNA alterations linked to sudden cardiac death in sports. Genetic testing is vital if the condition is to be caught in time, since most cases are asymptomatic and hard to diagnose by other means.

13 Oct 2009

New Case Editorial Boards to promote online participation of pathologists

PathXchange.org, a global online pathology community, announced the establishment of Case Editorial Boards (CEB) for over 20 pathology subspecialties to promote online participation and to ensure quality content in the portal.

13 Oct 2009

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

13 Oct 2009

Mouse model of ALS closely resembles humans with the paralyzing disorder, says report

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Sophora installs ChromoCure's cancer detection systems

ChromoCure, Inc. today announced its has executed a Joint Venture Agreement with Sophora Diagnostic Lab, Inc., a profitable New York based cancer pathology lab ("Sophora").

12 Oct 2009

BioImagene's new Digital Pathology Workstation launched at CAP ‘09 meeting

BioImagene, Inc., the leading provider of innovative digital pathology solutions, launched Crescendo – the new Digital Pathology Workstation (DPW) at the CAP ’09 – THE Pathologists’ Meeting™. The meeting is taking place from October 11 - 14, 2009 in the Gaylord National Harbor in Washington D.C.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

GE Healthcare (NYSE:GE) wishes to issue the following update and correction to its release NewsItemID 20090923005515 (GE-HEALTHCARE) "GE Healthcare Launches Global Initiative to Celebrate the 10th Anniversary of Digital Mammography" issued September 23, 2009/

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

NIH awards Beth Israel Deaconess Medical Center $38.2M in grants

Beth Israel Deaconess Medical Center (BIDMC) has been awarded $38.2 million in funding from the National Institutes of Health (NIH) as part of the American Recovery and Reinvestment Act of 2009 (ARRA).

12 Oct 2009

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine, have announced the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new treatments for HIV potentially slowing – or even preventing – the onset of AIDS.

11 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Pathology News and Research

Further Reading

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

AMP congratulates SACGHS on the publication of their DNA patenting report

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

Institute of Medicine elects researcher from The Children's Hospital of Philadelphia as its member

Brain researcher finds how the epilepsy and pain drug works

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Kinetic Concepts to showcase its ABThera OA NPT System at the American College of Surgeons Congress

New study launched to detect DNA alterations linked to sudden cardiac death in sports

New Case Editorial Boards to promote online participation of pathologists

New mouse models resembles human ALS; may provide important tool for screening new drugs

Mouse model of ALS closely resembles humans with the paralyzing disorder, says report

NIH funds the University of California's consortium for immune disorder research

Sophora installs ChromoCure's cancer detection systems

BioImagene's new Digital Pathology Workstation launched at CAP ‘09 meeting

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

Federal stimulus funds for comparative-effectiveness research in cancer

NIH awards Beth Israel Deaconess Medical Center $38.2M in grants

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News